7023 studies found for:    INS
Show Display Options
Rank Status Study
1 Terminated Treatment Satisfaction of Insulin Glargine Plus Insulin Apidra Compared With NPH Insulin Plus Insulin Apidra in Recently Diagnosed Type 1 Diabetes Children and Adolescents
Condition: Diabetes Type 1
Interventions: Drug: insulin Glargine + Insulin Apidra;   Drug: Insulin NPH + Insulin Apidra: Active Comparator
2 Completed
Has Results
U-500R Insulin In Type 2 Diabetes With Severe Insulin Resistance Via Omnipod
Conditions: Type 2 Diabetes;   Insulin Resistance
Intervention: Drug: U-500 Insulin delivered by Omnipod (disposable insulin pump)
3 Completed
Has Results
Pharmacokinetic and Glucodynamic Crossover Study of Subcutaneously (SC) Administered Insulin Lispro + Recombinant Human Hyaluronidase (rHuPH20) and Regular Human Insulin + rHuPH20 Compared to Insulin Lispro Alone
Condition: Diabetes Mellitus
Interventions: Drug: Insulin Lispro;   Drug: Regular Human Insulin;   Drug: rHuPH20
4 Completed Effect of a Basal/Pre-Meal Insulin Strategy (Detemir/Aspart) on Insulin Secretion and Action in Type 2 Diabetes
Condition: Type 2 Diabetes
Interventions: Drug: Long-acting bedtime insulin detemir (Levemir);   Drug: Insulin detemir and pre-meal insulin aspart.
5 Completed
Has Results
Comparison of the Efficacy and Safety of Two Insulin Intensification Strategies
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Insulin Lispro Low Mixture (LM);   Drug: Insulin Glargine;   Drug: Prandial Insulin Lispro
6 Completed
Has Results
Comparison of Insulin Detemir, Insulin Aspart and Biphasic Insulin Aspart 30 With OAD Treatment in Type 2 Diabetes
Conditions: Diabetes;   Diabetes Mellitus, Type 2
Interventions: Drug: biphasic insulin aspart;   Drug: insulin detemir;   Drug: insulin aspart
7 Enrolling by invitation Comparison Study of Insulin Glargine and NPH Insulin
Condition: Diabetes
Interventions: Drug: Switching to NPH insulin;   Drug: Continuation of insulin glargine
8 Completed
Has Results
Effect of Insulin Glulisine Compared to Insulin Aspart and Insulin Lispro When Administered by Continuous Subcutaneous Insulin Infusion (CSII) on Specific Pump Parameters in Patient With Type 1 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Insulin glulisine;   Drug: Insulin lispro;   Drug: Insulin aspart
9 Recruiting Glargine Insulin vs.Continuous Regular Insulin in Diabetic Surgical Patients Receiving Total Parenteral Nutrition
Condition: Diabetic Patients With Gastrointestinal Cancer Undergoing Surgery and Receiving Parenteral Nutrition
Interventions: Drug: Glargine Insulin;   Drug: Regular insulin
10 Completed
Has Results
Efficacy and Safety of Insulin Detemir Versus Neutral Protamine Hagedorn (NPH) Insulin in Pregnant Women With Type 1 Diabetes
Conditions: Diabetes;   Diabetes Mellitus, Type 1
Interventions: Drug: insulin detemir;   Drug: NPH insulin;   Drug: insulin aspart
11 Completed
Has Results
Safety and Efficacy Study of Insulin Lispro Versus Insulin Aspart in Participants With Type 2 Diabetes on Insulin Pump Therapy
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Insulin Lispro;   Drug: Insulin Aspart
12 Completed
Has Results
Insulin Lispro 6 Days Versus Insulin Aspart 6 Days in Pump Use
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Insulin lispro 2 day reservoir in-use;   Drug: Insulin lispro 6 day reservoir in-use;   Drug: Insulin aspart 6 day reservoir in-use
13 Terminated Weight Gain, Eating Patterns, and Development of Body Composition During Initiation of Basal Insulin Therapy in Patients With Type 2 Diabetes: A Comparison of Insulin Detemir and Insulin Glargine
Conditions: Diabetes;   Obesity
Interventions: Drug: insulin Levemir;   Drug: insulin Lantus
14 Completed Effect of NPH Insulin, Insulin Detemir and Insulin Glargine on GH-IGF-IGFBP Axis
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: NPH;   Drug: Detemir;   Drug: Glargine
15 Recruiting A Study To Compare the Effects of Insulin Peglispro and Glargine on Insulin Sensitivity and Meal Time Insulin Requirements in Type 2 Diabetics
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Insulin Peglispro;   Drug: Insulin Glargine;   Drug: Insulin Lispro
16 Completed
Has Results
Comparison of Insulins Aspart and Lispro in Insulin Pumps
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: Insulin Aspart;   Drug: Insulin Lispro
17 Completed
Has Results
A Trial Comparing Two Therapies: Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects With Type 2 Diabetes
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: exenatide;   Drug: insulin lispro;   Drug: Metformin;   Drug: Insulin/ Glargine
18 Unknown  Insulin Exposure and Glucose Response to Meals in Type 1 Diabetic Subjects Administered Two Different Insulin Regimens Compared to the Endogenous Insulin Exposure and Glucose Response to Meals In Healthy Adult Controls
Condition: Type 1 Diabetes
Interventions: Drug: Insulin glulisine;   Drug: Insulin
19 Completed Pharmacodynamic and Pharmacokinetic Effects of Insulin Glulisine in Obese Subjects With Type 2 Diabetes After a Standard Meal in Comparison to Insulin Aspart
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Insulin glulisine;   Drug: Insulin aspart
20 Completed A Comparison of Pharmacodynamics and Pharmacokinetics of Insulin Aspart, BIAsp70, BIAsp50 and Fast-acting Human Insulin
Condition: Diabetes Mellitus, Type 1
Intervention: Drug: Insulin Aspart, BIAsp 70, BIAsp50, Human Insulin

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years